249 related articles for article (PubMed ID: 7624382)
1. Enhancers increase the probability but not the level of gene expression.
Walters MC; Fiering S; Eidemiller J; Magis W; Groudine M; Martin DI
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7125-9. PubMed ID: 7624382
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin kappa gene enhancers synergistically activate gene expression but independently determine chromatin structure.
Blasquez VC; Hale MA; Trevorrow KW; Garrard WT
J Biol Chem; 1992 Nov; 267(33):23888-93. PubMed ID: 1429727
[TBL] [Abstract][Full Text] [Related]
3. A reporter system using a flow cytometer to detect promoter/enhancer activity in lymphoid cell lines.
Mazda O; Teshigawara K; Fujimoto S; Hattori N; Dou YM; Katsura Y
J Immunol Methods; 1994 Feb; 169(1):53-61. PubMed ID: 8133073
[TBL] [Abstract][Full Text] [Related]
4. In trans promoter activation by enhancers in transient transfection.
Smirnov NA; Akopov SB; Didych DA; Nikolaev LG
Gene; 2017 Mar; 603():15-20. PubMed ID: 27956170
[TBL] [Abstract][Full Text] [Related]
5. Resolving systematic errors in widely used enhancer activity assays in human cells.
Muerdter F; Boryń ŁM; Woodfin AR; Neumayr C; Rath M; Zabidi MA; Pagani M; Haberle V; Kazmar T; Catarino RR; Schernhuber K; Arnold CD; Stark A
Nat Methods; 2018 Feb; 15(2):141-149. PubMed ID: 29256496
[TBL] [Abstract][Full Text] [Related]
6. Activation of a truncated PR-1 promoter by endogenous enhancers in transgenic plants.
Beilmann A; Albrecht K; Schultze S; Wanner G; Pfitzner UM
Plant Mol Biol; 1992 Jan; 18(1):65-78. PubMed ID: 1731979
[TBL] [Abstract][Full Text] [Related]
7. DNA replication facilitates the action of transcriptional enhancers in transient expression assays.
Wilson AC; Patient RK
Nucleic Acids Res; 1993 Sep; 21(18):4296-304. PubMed ID: 8414985
[TBL] [Abstract][Full Text] [Related]
8. Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation.
Schübeler D; Lorincz MC; Cimbora DM; Telling A; Feng YQ; Bouhassira EE; Groudine M
Mol Cell Biol; 2000 Dec; 20(24):9103-12. PubMed ID: 11094062
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional enhancers act in cis to suppress position-effect variegation.
Walters MC; Magis W; Fiering S; Eidemiller J; Scalzo D; Groudine M; Martin DI
Genes Dev; 1996 Jan; 10(2):185-95. PubMed ID: 8566752
[TBL] [Abstract][Full Text] [Related]
10. Enhancer regions of ovine interferon-tau gene that confer PMA response or cell type specific transcription.
Yamaguchi H; Nagaoka K; Imakawa K; Sakai S; Christenson RK
Mol Cell Endocrinol; 2001 Feb; 173(1-2):147-55. PubMed ID: 11223186
[TBL] [Abstract][Full Text] [Related]
11. Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators.
Pikaart MJ; Recillas-Targa F; Felsenfeld G
Genes Dev; 1998 Sep; 12(18):2852-62. PubMed ID: 9744862
[TBL] [Abstract][Full Text] [Related]
12. Heme oxygenase-1 gene enhancer manifests silencing activity in a chromatin environment prior to oxidative stress.
Dohi Y; Alam J; Yoshizumi M; Sun J; Igarashi K
Antioxid Redox Signal; 2006; 8(1-2):60-7. PubMed ID: 16487038
[TBL] [Abstract][Full Text] [Related]
13. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
Duan H; Heckman CA; Boxer LM
Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
[TBL] [Abstract][Full Text] [Related]
14. Position effects are influenced by the orientation of a transgene with respect to flanking chromatin.
Feng YQ; Lorincz MC; Fiering S; Greally JM; Bouhassira EE
Mol Cell Biol; 2001 Jan; 21(1):298-309. PubMed ID: 11113204
[TBL] [Abstract][Full Text] [Related]
15. Chromatin structures of the rat tyrosine aminotransferase gene relate to the function of its cis-acting elements.
Nitsch D; Stewart AF; Boshart M; Mestril R; Weih F; Schütz G
Mol Cell Biol; 1990 Jul; 10(7):3334-42. PubMed ID: 1972541
[TBL] [Abstract][Full Text] [Related]
16. [Transcriptional activity of WT1 gene promoter and enhancer in diverse cell lines].
Hu SY; Chen ZX; Zhao Y; Cen JN; Gu M; Fu ZZ; He J; Gu WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1050-5. PubMed ID: 17956689
[TBL] [Abstract][Full Text] [Related]
17. Developmental acquisition of enhancer function requires a unique coactivator activity.
Majumder S; Zhao Z; Kaneko K; DePamphilis ML
EMBO J; 1997 Apr; 16(7):1721-31. PubMed ID: 9130716
[TBL] [Abstract][Full Text] [Related]
18. Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential.
Weber EL; Cannon PM
Hum Gene Ther; 2007 Sep; 18(9):849-60. PubMed ID: 17767401
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of 5-methylcytosine DNA glycosylase in human embryonic kidney cells EcR293 demethylates the promoter of a hormone-regulated reporter gene.
Zhu B; Benjamin D; Zheng Y; Angliker H; Thiry S; Siegmann M; Jost JP
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5031-6. PubMed ID: 11296268
[TBL] [Abstract][Full Text] [Related]
20. Ciona Brachyury proximal and distal enhancers have different FGF dose-response relationships.
Harder MJ; Hix J; Reeves WM; Veeman MT
PLoS Genet; 2021 Jan; 17(1):e1009305. PubMed ID: 33465083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
